QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
QQQ   445.50 (+0.15%)
AAPL   171.32 (-1.15%)
MSFT   421.14 (-0.07%)
META   490.57 (-0.67%)
GOOGL   150.71 (-0.11%)
AMZN   181.19 (+0.76%)
TSLA   176.61 (-1.79%)
NVDA   910.28 (+0.86%)
NIO   4.71 (+0.86%)
AMD   181.70 (+1.17%)
BABA   72.32 (+1.02%)
T   17.52 (-0.17%)
F   13.22 (+1.23%)
MU   117.62 (-1.28%)
CGC   9.02 (-5.55%)
GE   177.12 (-1.67%)
DIS   123.09 (+1.74%)
AMC   3.82 (-11.98%)
PFE   27.85 (+0.25%)
PYPL   66.66 (+0.14%)
XOM   115.30 (+0.29%)
NYSE:CPHI

China Pharma (CPHI) Stock Price, News & Analysis

$0.37
-0.06 (-13.11%)
(As of 10:03 AM ET)
Today's Range
$0.36
$0.41
50-Day Range
$0.34
$0.55
52-Week Range
$0.32
$2.70
Volume
47,383 shs
Average Volume
375,352 shs
Market Capitalization
$2.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CPHI stock logo

About China Pharma Stock (NYSE:CPHI)

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. The company also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. The company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

CPHI Stock Price History

CPHI Stock News Headlines

StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)
China Pharma Holding Inc
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
China Pharma Holdings, Inc. (CPHI)
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
China Pharma Holdings Issues 15M Unregistered Shares
China SXT Pharmaceuticals Inc (SXTC)
China Pharma Holdings Inc.
CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA
Kexing Biopharm Attended CPHI Worldwide 2023
See More Headlines
Receive CPHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/15/2018
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Employees
234
Year Founded
N/A

Profitability

Net Income
$-3,970,000.00
Pretax Margin
-39.99%

Debt

Sales & Book Value

Annual Sales
$7.78 million
Book Value
$2.86 per share

Miscellaneous

Free Float
3,559,000
Market Cap
$2.50 million
Optionable
Not Optionable
Beta
0.91
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Ms. Zhilin Li (Age 71)
    President, CEO, Chairman & Interim CFO
    Comp: $241.6k
  • Ms. Huang Na C.F.A.
    BOD Secretary & IR Manager

CPHI Stock Analysis - Frequently Asked Questions

How have CPHI shares performed in 2024?

China Pharma's stock was trading at $0.6050 at the start of the year. Since then, CPHI stock has decreased by 36.6% and is now trading at $0.3833.
View the best growth stocks for 2024 here
.

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSE:CPHI) announced its quarterly earnings data on Wednesday, August, 15th. The company reported ($1.00) EPS for the quarter. The company earned $3.17 million during the quarter. China Pharma had a negative trailing twelve-month return on equity of 64.09% and a negative net margin of 39.99%.

When did China Pharma's stock split?

Shares of China Pharma reverse split on Wednesday, March 6th 2024. The 1-5 reverse split was announced on Wednesday, March 6th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 6th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What other stocks do shareholders of China Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include iShares Silver Trust (SLV), Check-Cap (CHEK), ContraFect (CFRX), Clear Channel Outdoor (CCO), Boxlight (BOXL), Bionano Genomics (BNGO), Athersys (ATHX), Assertio (ASRT), AMC Entertainment (AMC).

How do I buy shares of China Pharma?

Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CPHI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners